Mark Malesker, PharmD, discusses the clinical evidence, drug interaction risks, and formulary challenges surrounding cannabinoid use for sleep disorders.
Objective: Health care resource utilization (HCRU) and cost among Medicaid patients with serious mental illness (SMI) were ...
AJMC: 64% of patients who responded to pCR skipped traditional chemotherapy entirely, and 97% avoided anthracyclines. For patients and oncologists, what does that mean in practice, and how do you ...
After decades of neglect, malnutrition-related diabetes, or type 5, is finally getting the research, recognition, and ...
In this episode titled, 'Understanding Neuroendocrine Carcinomas: Definitions, Types, and Clinical Presentation,' Ryan Haumschil ...
New factor XIa inhibitors cut recurrent non-cardioembolic stroke without extra bleeding—plus what milvexian and abilacimab trials reveal. In this installment of this series, ‘The Future of Factor XIa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results